Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cannon RD et al. - The heterologous expression of efflux pumps in model systems, such Saccharomyces cerevisiae, has enabled the functional analysis of efflux pumps from a variety of fungi. Phylogenetic analysis of the ABC pleiotropic drug resistance family has provided a new view of the evolution of this important class of efflux pumps. There are several ways in which the clinical significance of efflux-mediated antifungal drug resistance can be mitigated. Alternative antifungal drugs, such as the echinocandins, that are not efflux pump substrates provide one option. Potential therapeutic approaches that could overcome azole resistance include targeting efflux pump transcriptional regulators and fungal stress response pathways, blockade of energy supply, and direct inhibition of efflux pumps.

Related Articles

Antifungal drug resistance: do molecular methods provide a way forward
Current Opinion in Infectious Diseases, 11/02/09    Relevance Score: 68%

Issues in the design and interpretation of antifungal drug trials in the critically ill
Current Opinion in Infectious Diseases, 10/28/09    Relevance Score: 66%

New imagining technique could lead to better antibiotics and cancer drugs
EurekAlert, 11/10/09    Relevance Score: 65%

Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study
Haematologica, 10/27/09    Relevance Score: 65%

Successful Use of Topical Voriconazole 1% Alone as First-Line Antifungal Therapy Against Candida albicans Keratitis
Annals of Pharmacotherapy, 10/28/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address